Skin cancer is the most common malignancy in humans and accounts for one-third of newly diagnosed cancers. Basal cell carcinoma (BCC) is one of the most prevalent and persistent types, and appears in two main histological forms, superficial and nodular. Typical treatments include surgery; however, this may leave scarring, which is undesirable, especially in facial lesions. We report the results of seven individual patients with one or more BCCs (both nodular and superficial) treated with imiquimod 5% cream. Eleven of 13 lesions cleared following daily topical treatment for 10-18 weeks. Any local skin reactions resolved at the end of treatment.
Tipologia: | Articolo su rivista |
Citazione: | Bianchi, L., Costanzo, A., Campione, E., Nisticò, S.P., & Chimenti, S. (2003). Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 28(SUPPL 1), 24-26. |
IF: | Con Impact Factor ISI |
Lingua: | English |
Settore Scientifico Disciplinare: | Settore MED/35 - Malattie Cutanee e Veneree |
Revisione (peer review): | Sì, ma tipo non specificato |
Tipo: | Articolo |
Rilevanza: | Rilevanza internazionale |
Stato di pubblicazione: | Pubblicato |
Data di pubblicazione: | 2003 |
Titolo: | Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients |
Autori: | |
Autori: | Bianchi, L; Costanzo, A; Campione, E; Nisticò, SP; Chimenti, S |
Appare nelle tipologie: | 01 - Articolo su rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Superficial and nodular basal cell carcinomas treated with...Clinical and Experimental Dermatology, 2003, 28 (Suppl. 1), 24–26.pdf | N/A | Copyright dell'editore | Administrator Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.